China releases white paper on controlling fentanyl-related substances
China and U.S. flags are displayed alongside a miniature worker in this illustration picture taken November 7, 2024. REUTERS/Florence Lo/Illustration/File Photo
BEIJING (Reuters) - China opposes accusations and the shifting of responsibility on the issue of fentanyl-related substances, according to an official white paper released on Tuesday, Xinhua reported.
China has carried out "in-depth" cooperation with relevant countries, including the U.S., in addressing the issue of fentanyl-related substances and their precursors, the white paper said, adding that cooperations have "achieved significant results".
U.S. President Donald Trump increased tariffs on all Chinese imports to 20% from the previous 10% levy on Tuesday to punish Beijing for failing to halt shipments of the deadly opioid fentanyl to the U.S.
(Reporting by Xiuhao Chen and Ryan Woo, Editing by Louise Heavens)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Australia and Vietnam deepen strategic partnership
- SEC settles charges over SpaceX, Klarna, pre-IPO share fraud
- Russian attacks on Ukraine's Zaporizhzhia, Kyiv kill five, officials say
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share